The Supreme Court issued a ruling on the abortion drug mifepristone.
The nation’s highest court blocked a ruling from a federal judge in Texas that placed restrictions on the FDA’s approval of the drug, which is used in about half of all abortions. The Supreme Court ruled to allow the approval of the drug while a lawsuit proceeds in federal court, granting requests from the Biden administration and the manufacturer.
“The applications for stays presented to JUSTICE ALITO and by him referred to the Court are granted,” the Court wrote in its decision. “The April 7, 2023 order of the United States District Court for the Northern District of Texas, case No. 2:22–cv–223, is stayed pending disposition of the appeal in the United States Court of Appeals for the Fifth Circuit and disposition of a petition for a writ of certiorari, if such a writ is timely sought. Should certiorari be denied, this stay shall terminate automatically. In the event certiorari is granted, the stay shall terminate upon the sending down of the judgment of this Court.”
This is a breaking story; refresh for updates…
